Voyager Therapeutics, Inc. - Laporan Laba Rugi (TTM)

Voyager Therapeutics, Inc.
US ˙ NasdaqGS ˙ US92915B1061

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Voyager Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 197 171 160 132 16 37 32 31 71 41 191 195 158 250 119 144 164 80 67 43
Change (%) -13.25 -6.76 -17.12 -87.99 135.63 -15.62 -2.04 128.05 -42.00 366.25 2.17 -18.72 57.84 -52.38 20.77 13.92 -51.15 -16.30 -36.41
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 123 109 99 89 82 74 66 59 60 56 65 74 81 92 101 111 115 125 129 128
Change (%) -11.80 -9.15 -10.04 -8.01 -9.76 -10.84 -10.61 2.42 -7.42 16.53 14.55 8.77 13.84 9.25 9.90 3.96 8.30 3.56 -0.48
% of Revenue 62.51 63.55 61.92 67.22 514.91 197.21 208.38 190.16 85.40 136.32 34.07 38.20 51.12 36.87 84.59 76.97 70.24 155.74 192.70 301.56
Gross Operating Profit 74 62 61 43 -66 -36 -34 -28 10 -15 126 120 77 158 18 33 49 -45 -62 -86
Change (%) -15.66 -2.59 -28.65 -251.97 -44.79 -5.92 -18.51 -136.93 -244.28 -946.38 -4.23 -35.70 103.84 -88.38 80.43 47.23 -191.48 39.19 38.27
% of Revenue 37.49 36.45 38.08 32.78 -414.91 -97.21 -108.38 -90.16 14.60 -36.32 65.93 61.80 48.88 63.13 15.41 23.03 29.76 -55.74 -92.70 -201.56
SG&A 37 35 35 37 37 37 35 32 31 31 32 33 34 36 35 37 37 36 37 37
Change (%) -4.43 -1.32 6.37 1.19 0.22 -5.60 -8.21 -4.36 0.36 4.42 2.29 2.87 5.23 -1.18 5.25 -0.24 -3.36 2.88 0.93
% of Revenue 18.56 20.45 21.64 27.77 234.05 99.55 111.37 104.36 43.77 75.73 16.96 16.98 21.49 14.33 29.74 25.92 22.69 44.90 55.19 87.59
R&D
Change (%)
% of Revenue
OpEx 160 144 133 126 119 111 101 91 91 87 97 108 115 128 136 148 152 161 166 166
Change (%) -10.12 -7.24 -5.79 -5.32 -6.64 -9.08 -9.77 0.02 -4.78 12.21 10.48 6.95 11.29 6.33 8.69 2.90 5.45 3.41 -0.17
% of Revenue 81.07 84.00 83.56 94.99 748.96 296.76 319.75 294.52 129.17 212.05 51.03 55.18 72.61 51.20 114.32 102.89 92.93 200.64 247.89 389.15
Operating Income 37 27 26 7 -103 -74 -69 -60 -21 -46 93 87 43 122 -17 -4 12 -81 -99 -123
Change (%) -26.67 -4.22 -74.74 -1,655.69 -28.56 -5.76 -13.29 -65.80 122.81 -303.76 -6.49 -50.32 181.22 -113.98 -75.65 -378.78 -795.56 22.99 24.34
% of Revenue 18.93 16.00 16.44 5.01 -648.96 -196.76 -219.75 -194.52 -29.17 -112.05 48.97 44.82 27.39 48.80 -14.32 -2.89 7.07 -100.64 -147.89 -289.15
Interest Expense -0 -0 -0 -0
Change (%) -0.00 -0.00 -0.00
% of Revenue -1.04 -1.24 -1.26 -0.55
Net Income 40 37 39 18 -93 -71 -71 -60 -17 -46 99 96 52 132 -3 9 26 -65 -85 -108
Change (%) -8.36 7.11 -54.48 -618.15 -23.31 -0.46 -15.57 -71.47 171.82 -313.23 -3.15 -45.42 152.98 -102.30 -396.42 186.82 -351.17 30.29 27.44
% of Revenue 20.32 21.47 24.66 13.55 -584.62 -190.29 -224.46 -193.46 -24.21 -113.45 51.88 49.18 33.02 52.93 -2.56 6.28 15.80 -81.25 -126.49 -253.49

Source: Capital IQ

Other Listings
MX:VYGR
DE:VT6 € 3.18
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista